Exelixis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.About EXEL
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.
CEOMichael M. Morrissey
CEOMichael M. Morrissey
Employees1,147
Employees1,147
HeadquartersAlameda, California
HeadquartersAlameda, California
Founded1994
Founded1994
Employees1,147
Employees1,147
EXEL Key Statistics
Market cap10.21B
Market cap10.21B
Price-Earnings ratio18.53
Price-Earnings ratio18.53
Dividend yield—
Dividend yield—
Average volume2.36M
Average volume2.36M
High today$38.64
High today$38.64
Low today$37.71
Low today$37.71
Open price$38.55
Open price$38.55
Volume1.54M
Volume1.54M
52 Week high$49.62
52 Week high$49.62
52 Week low$25.12
52 Week low$25.12
EXEL News
TipRanks 1d
Exelixis’s Promising Study on Renal Cell Carcinoma: A Potential Game Changer?Exelixis ((EXEL)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...
Analyst ratings
57%
of 21 ratingsBuy
57.1%
Hold
42.9%
Sell
0%
People also own
Based on the portfolios of people who own EXEL. This list is generated using Robinhood data, and it’s not a recommendation.